Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:48 AM
Ignite Modification Date:
2025-12-25 @ 2:48 AM
NCT ID:
NCT05949333
Eligibility Criteria:
Inclusion Criteria:
* Women aged 18 to 75 years old as of the date of study registration.
* Patients with histologically confirmed invasive adenocarcinoma.
* Patients with confirmed estrogen receptor, progesterone receptor, and Her2 receptor status.
* Patients with Eastern Cooperative Oncology Group (ECOG) performance status 0-1.
* Patients with a left ventricular ejection fraction (LVEF) ≥55%.
* Patients who have agreed to participate in this trial and have provided written consent.
Exclusion Criteria:
* Patients with a history of breast cancer treatment
* Patients with a history of chemotherapy, radiation therapy, immunotherapy, or biotherapy for malignancies other than breast cancer
* Patients with infectious diseases
* Patients with serious illnesses that may affect this clinical trial: cardiovascular disease, kidney disease, liver disease, endocrine disease, tumors, or diabetes
* Other individuals deemed by the clinical trial investigators to be unable to participate in the trial.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT05949333
Study Brief:
Protocol Section:
NCT05949333